Roundup cancer attorney pleads guilty to extortion attempt

A Virginia lawyer who helped represent the first Roundup cancer plaintiff to take Monsanto to trial pleaded guilty on Friday to trying to extort $200 million from a chemical compound supplier to Monsanto. Timothy Litzenburg, 38, admitted to a scheme in which he and another lawyer threatened to inflict substantial “financial and reputational harm” on … Continue reading “Roundup cancer attorney pleads guilty to extortion attempt”

2020 Mid Year Update: Mass Tort and Class Action Litigation Outlook

While many courtrooms across the country were closed in response to the COVID-19 pandemic, there are several mass torts that continued making significant progress despite the legal hiatus. Two of these were cited in our 2020 forecast: JUUL The JUUL MDL (Northern District of California) has continued to move forward since the end of 2019. … Continue reading “2020 Mid Year Update: Mass Tort and Class Action Litigation Outlook”

Litigation Update: Talc Lawsuits Developments for Chanel, L’Oreal and Imerys

In the wake of lawsuits filed against Chanel and other manufacturers and sellers, linking cancer to their talc products, the company, along with cosmetic giants Revlon and L’Oreal are considering alternatives to talc in some of their products.  Chanel has removed talc from a loose face powder and discontinued its talc body powder.  Revlon has … Continue reading “Litigation Update: Talc Lawsuits Developments for Chanel, L’Oreal and Imerys”

Litigation Update: Elmiron Linked to Serious Eye Injuries

Elmiron [Pentosan Polysulfate Sodium (PPS)] is a drug developed in 1996 by Johnson & Johnson’s subsidiary, Janssen Pharmaceuticals to treat interstitial cystitis, bladder pain and osteoarthritis.  The drug has been linked to serious eye injuries including pigmentary and retinal maculopathy and macular degeneration.  Interstitial cystitis is a disease that causes severe bladder pain and urinary … Continue reading “Litigation Update: Elmiron Linked to Serious Eye Injuries”

Fresh talk of a settlement between Bayer and Roundup cancer patients

There was renewed talk of a potential settlement this week between Bayer AG and tens of thousands of cancer patients as a key court hearing looms next week. According to a report in Bloomberg, lawyers for Bayer have reached verbal agreements with U.S. lawyers representing at least 50,000 plaintiffs who are suing Monsanto over claims … Continue reading “Fresh talk of a settlement between Bayer and Roundup cancer patients”

How Will J&J’s Move to Discontinue Baby Powder Sales Impact Its Ongoing Talc Litigation Now?

On May 19, 2020, Johnson & Johnson announced it is discontinuing North American sales of its talc-based baby powder, a product it has defended for decades in the face of lawsuits filed by consumers who say it caused cancer. This move likely would not have happened without the public attention drawn to individuals who have … Continue reading “How Will J&J’s Move to Discontinue Baby Powder Sales Impact Its Ongoing Talc Litigation Now?”

Litigation Update: J&J to Discontinue Sales of Baby Powder in North America

Even as the company continues to defend the safety of its flagship product, pharmaceutical giant Johnson & Johnson announced on Tuesday that it would discontinue selling its talc-based baby powder product in the U.S.   Facing tens of thousands of lawsuits from women alleging their ovarian cancer was caused by asbestos contamination of J&J baby powder, … Continue reading “Litigation Update: J&J to Discontinue Sales of Baby Powder in North America”

ILSI is a Food Industry Front Group, New Study Suggests

News Release For Immediate Release: Sunday, May 17th 2020 at 8pm EDT For More Information Contact: Gary Ruskin +1 415 944 7350 The influential global nonprofit group International Life Sciences Institute (ILSI) says that its mission is to “improve the well-being of the general public,” but a study published today in Public Health Nutrition adds evidence that … Continue reading “ILSI is a Food Industry Front Group, New Study Suggests”

Dicamba Fact Sheet

Dicamba (3,6-dichloro-2-methoxybenzoic acid) is a broad-spectrum herbicide first registered in 1967. The herbicide is used on agricultural crops, fallow land, pastures, turfgrass and rangeland. Dicamba is also registered for non-agricultural uses in residential areas and other sites, such as golf courses. At these types of sites, it is primarily used to control broadleaf weeds such as dandelions, chickweed, … Continue reading “Dicamba Fact Sheet”

Litigation Update: California Appeals Court Reinstates Thousands of Risperdal Cases Against Johnson & Johnson

On May 8, the California 2nd District Court of Appeals reinstated thousands of cases pending against drug manufacturer Johnson & Johnson involving the antipsychotic drug Risperdal.  The March, 2017 lower court ruling in the Risperdal and Invega Products Liability Cases had granted motions for summary judgment in favor of J&J on preemption grounds in five … Continue reading “Litigation Update: California Appeals Court Reinstates Thousands of Risperdal Cases Against Johnson & Johnson”

Copyright ©2021 Medical Injury Help, ForLawFirmsOnly Marketing, Inc. All Rights Reserved